Finance

Lists
688526:SHA
Wuhan Keqian Biology Co Ltd
CN¥11.32
-0.53%
(-0.060) 1D
Nov 17, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688526...
Open
CN¥11.36
High
CN¥11.50
Low
CN¥11.20
Mkt. cap
5.30B
Avg. vol.
1.18M
Volume
1.24M
Dividend
5.65%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
23.08
52-wk high
CN¥17.81
52-wk low
CN¥11.11
EPS
CN¥0.49
No. of employees
935
Open
CN¥11.36
High
CN¥11.50
Low
CN¥11.20
Mkt. cap
5.30B
Avg. vol.
1.18M
Volume
1.24M
Dividend
5.65%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
23.08
52-wk high
CN¥17.81
52-wk low
CN¥11.11
EPS
CN¥0.49
No. of employees
935
News stories
From web sources and news partners
About Wuhan Keqian Biology Co Ltd
CEO-
Employees935
FoundedJan 11, 2001
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitekqbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
211.88M
227.54M
146.29M
201.07M
Cost of goods sold
86.92M
81.91M
78.95M
79.35M
Cost of revenue
86.92M
81.91M
78.95M
79.35M
Research and development expenses
24.54M
25.10M
34.34M
29.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.58M
35.67M
34.00M
39.38M
Operating expense
89.78M
64.34M
68.80M
56.65M
Total operating expenses
176.70M
146.25M
147.75M
136.00M
Operating income
35.18M
81.28M
-1.46M
65.07M
Other non operating income
2.18M
559.75K
-1.19M
17.71M
EBT including unusual items
92.57M
90.10M
38.63M
32.38M
EBT excluding unusual items
55.13M
94.15M
8.42M
66.38M
Income tax expense
12.23M
11.42M
2.60M
2.63M
Effective tax rate
13.21%
12.67%
6.73%
8.12%
Other operating expenses
11.28M
-3.75M
4.42M
-9.23M
Net income
80.93M
79.24M
36.49M
30.34M
Net profit margin
38.20%
34.82%
24.94%
15.09%
Earnings per share
-
-
-
-
Interest and investment income
18.66M
12.38M
10.54M
142.14K
Interest expense
-
-72.17K
-69.97K
-15.93M
Net interest expenses
18.66M
12.30M
10.47M
-15.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
63.12M
109.22M
29.59M
93.01M
Gain or loss from assets sale
6.90M
-
1.90M
-1.90M
Upcoming events
AI content may include mistakes. Learn more
Google apps